The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals
- 31 August 2005
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 181 (2), 275-284
- https://doi.org/10.1016/j.atherosclerosis.2005.01.036
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The genetics of haemostasis: a twin studyThe Lancet, 2001
- Hemostatic Risk Factors for Atherothrombotic Disease: An Epidemiologic ViewThrombosis and Haemostasis, 2001
- HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Regional Variation in Plasminogen Activator Inhibitor-1 Expression in Adipose Tissue from Obese IndividualsThrombosis and Haemostasis, 2000
- PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular EventsThrombosis and Haemostasis, 1997
- Five Frequent Polymorphisms of the PAI-1 GeneArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.Proceedings of the National Academy of Sciences, 1995
- Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Glucocorticoid and Cyclic Nucleotide Regulation of Plasminogen Activator and Plasminogen Activator-Inhibitor Gene Expression in Primary Cultures of Rat HepatocytesMolecular Endocrinology, 1989
- Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.Heart, 1988